New Research Suggests That People With A Sleep Disorder Have A Higher Risk Of Developing Dementia - Alzheimer's Society Comment
People who experience rapid eye movement sleep behaviour disorder (RBD) may go on to develop conditions such as dementia with Lewy bodies, Parkinson's disease, or multiple system atrophy. The researchers studied the medical records of 27 people with these three neurodegenerative conditions who had also experienced RBD earlier in life...

New Pathway To Parkinson's And Alzheimer's Diseases
Although their genetic underpinnings differ, Alzheimer's disease, Parkinson's disease and Huntington's disease are all characterized by the untimely death of brain cells...

REM Sleep Disorder Could Be Early Warning Of Parkinson's, Dementia That Develops Decades Later
American neurologists and sleep experts suggest in a recent study that rapid eye movement (REM) sleep behavior disorder could be an early sign of Parkinson's disease or dementia that develops up to 50 years later. You can read how neurologist and sleep specialist Dr Bradley F...

Global Breakthrough In Treatment Of Dementia 'Within Reach' - Clinical Trial In Scotland Recruiting
A Glasgow-based medical research company is leading a worldwide sleep study which could radically reduce the symptoms associated with dementia. The groundbreaking trial, conducted by CPS Research, is the first of its kind to investigate the use of sleep hormone melatonin as an add on treatment for dementia. The study is already showing remarkable initial results in volunteers from Scotland...

UK In Bottom Third Of Countries For Dementia Drug Usage
The UK ranks 11th out of 14 countries for dementia drug use rates according to a report published by the Department of Health. The paper 'Extent and causes of international variations in drug usage' by Professor Sir Mike Richards looked at the rates of drug usage per capita for a range of diseases and drug categories in 14 countries across the world. The UK's overall ranking was eighth...

Alzheimer's Foundation Of America And Second Wind Dreams Forge Strategic Partnership
The Alzheimer's Foundation of America (AFA), New York, NY, and Second Wind Dreams (SWD), Marietta, GA, announced that they have forged a strategic partnership that will utilize their combined expertise, program strengths and local membership bases to further raise the bar on care for the increasing number of individuals nationwide with Alzheimer's disease and related dementias...

Eisai Inc. And Pfizer Inc Announce U.S. FDA Approval For New Higher-Dose Aricept(R) 23 Mg Tablet For The Treatment Of Moderate-To-Severe AD
Eisai Inc. and Pfizer Inc [NYSE: PFE] announced that the U.S. Food and Drug Administration (FDA) approved a new once-daily, higher-dose Aricept (donepezil HCl) 23 mg tablet for the treatment of moderate-to-severe Alzheimer's disease (AD). Aricept 23 mg tablet offers another dosing option for patients with moderate-to-severe AD, for whom few treatments are available...

More Education, Less Dementia Risk
A team of researchers from the UK and Finland has discovered why people who stay in education longer have a lower risk of developing dementia - a question that has puzzled scientists for the past decade...

New Partnership With Open-Access Journal Molecular Neurodegeneration Announced By American Health Assistance Foundation
The American Health Assistance Foundation (AHAF)has announced a new partnership with BioMed Central's open access journal, Molecular Neurodegeneration (MN) in which the publication will be the official open access journal of AHAF...

Anti-Ageing Gene Linked To Alzheimer's
SIRT1, a gene associated with anti-ageing has been linked to the production of an Alzheimer's protein according to a study in Cell. Researchers at MIT found that SIRT1 appears to prevent production of damaging A-beta peptides that make up amyloid plaques which form in the brain of people with Alzheimer's...

Age-Related Cognitive Decline Reversed By Brain Training
Specialized brain training targeted at the regions of a rat's brain that process sound reversed many aspects of normal, age-related cognitive decline and improved the health of the brain cells, according to a new study from researchers at University of California, San Francisco...

Government Outlines Details Of How It Plans To Address Social Care Problems, UK
More details about how the government plans to address the problem of providing care and support for an ageing population were unveiled by Secretary of State for Health, Andrew Lansley...

Alzheimer's Association Litigation Update
The Alzheimer's Association has become aware of a misleading message from the CEO of the Alzheimer's Foundation of America dated July 19, 2010. We deny and dispute all of the allegations against our Association in this letter and in AFA's lawsuit against us. We are proud of our 30 years of providing care and support to those impacted by Alzheimer's and advancing critical research...

Neuronetrix Showcases New Cognitive Testing Device At The Alzheimer's Association Annual Meeting
This week at ICAD 2010, Neuronetrix for the first time publicly demonstrated their COGNISION™ System, an innovative platform which enables objective assessment of cognitive function. The demonstration focused on the COGNISION™ System's ability, using a non-invasive technology called event-related potentials (ERP), to accurately measure the cognitive performance of a patient's brain...

Prana's Research Was Presented At International Conference On Alzheimer's Disease On July 14
Prana Biotechnology Limited (NASDAQ: PRAN) (ASX: PBT), Head of Research, Assoc. Prof. Robert Cherny, presented new data on PBT2, the Company's lead compound in development for Alzheimer's Disease on July 14th at the prestigious International Conference of Alzheimer's Disease (ICAD) in Honolulu...